{"id":"d379bc4f-a144-46c8-8c2a-17554ab559e1","name":"SS Innovations International","slug":"ss-innovations","description":"US-based medical technology company (Nasdaq: SSII) developing the SSi Mantra multi-specialty surgical robotic system. Founded by Dr. Sudhir Srivastava, a globally acclaimed robotic cardiac surgeon, the company aims to make robotic surgery more affordable and accessible globally. The SSi Mantra 3 system covers general, urological, colorectal, gynecological, and cardiac surgical indications, and the company submitted its FDA 510(k) filing in late 2025.","status":null,"founded":null,"hq":"United States","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","sources":[{"url":"https://www.massdevice.com/ss-innovations-submits-mantra-robot-fda/","title":"SS Innovations submits Mantra robot to FDA","sourceName":"MassDevice"},{"url":"https://www.biopharmaboardroom.com/news/6/4101/ss-innovations-submits-510k-application-to-fda-for-ssi-mantra-surgical-robotic-system.html","title":"SS Innovations Submits 510(k) Application to FDA","sourceName":"BioPharma Boardroom"}],"keyFacts":[{"label":"Ticker","value":"Nasdaq: SSII"},{"label":"Systems installed","value":"138 across 8 countries"},{"label":"Procedures performed","value":"7,300+"},{"label":"FDA status","value":"510(k) submitted late 2025"},{"label":"CEO","value":"Dr. Sudhir Srivastava"},{"label":"Stock","value":"Nasdaq: SSII"},{"label":"Product","value":"SSi Mantra 3 surgical robotic system"},{"label":"Funding raised","value":"8.6M (2025)"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"createdAt":"2026-07-02T14:59:44.499Z","updatedAt":"2026-07-02T17:41:50.882Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/ss-innovations","url":"https://registry.deploy.report/companies/ss-innovations","name":"SS Innovations International","description":"US-based medical technology company (Nasdaq: SSII) developing the SSi Mantra multi-specialty surgical robotic system. Founded by Dr. Sudhir Srivastava, a globally acclaimed robotic cardiac surgeon, the company aims to make robotic surgery more affordable and accessible globally. The SSi Mantra 3 system covers general, urological, colorectal, gynecological, and cardiac surgical indications, and the company submitted its FDA 510(k) filing in late 2025.","identifier":"d379bc4f-a144-46c8-8c2a-17554ab559e1","address":"United States","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":2,"primary_source_types":[]}}}